financetom
Business
financetom
/
Business
/
--Boyd Gaming Keeps Quarterly Dividend at $0.17 per Share, Payable Oct. 15 to Holders of Record on Sept. 15
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Boyd Gaming Keeps Quarterly Dividend at $0.17 per Share, Payable Oct. 15 to Holders of Record on Sept. 15
Aug 20, 2024 2:11 PM

04:19 PM EDT, 08/20/2024 (MT Newswires) --

Price: 58.51, Change: +0.02, Percent Change: +0.03

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Protagonist Therapeutics' Q4 Earnings, License and Collaboration Revenue Rise
Protagonist Therapeutics' Q4 Earnings, License and Collaboration Revenue Rise
Feb 21, 2025
07:24 AM EST, 02/21/2025 (MT Newswires) -- Protagonist Therapeutics ( PTGX ) reported Q4 earnings Friday of $1.98 per diluted share, up from $0.44 a year earlier. License and collaboration revenue for the quarter ended Dec. 31 was $170.6 million, compared with $60 million a year earlier. The company said it expects its cash, cash equivalents and marketable securities of...
Peyto Exploration Develops Record 76.2 Million MMboe Reserves in 2024
Peyto Exploration Develops Record 76.2 Million MMboe Reserves in 2024
Feb 21, 2025
07:25 AM EST, 02/21/2025 (MT Newswires) -- Peyto Exploration & Development ( PEYUF ) overnight Thursday said its 2024 drilling program developed a record 76.2 million barrels of oil equivalent (MMboe) of new Proved Developed Producing (PDP) reserves. The company estimates a total base decline rate of 27% this year, from December's monthly average production of 136 Mboe/d. Its capital...
Johnson & Johnson's Subcutaneous Ulcerative Colitis Treatment Shows 'Significant' Improvements
Johnson & Johnson's Subcutaneous Ulcerative Colitis Treatment Shows 'Significant' Improvements
Feb 21, 2025
07:26 AM EST, 02/21/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday that data from a phase 3 study of Tremfya subcutaneous induction therapy in adults with moderately to severely active ulcerative colitis showed statistically significant and clinically meaningful improvements compared to a placebo. The company said the results for the drug, also called guselkumab, were consistent...
Stellantis Reportedly Halts Assembly Plant in Canada Amid Product Strategy Review
Stellantis Reportedly Halts Assembly Plant in Canada Amid Product Strategy Review
Feb 21, 2025
07:26 AM EST, 02/21/2025 (MT Newswires) -- Stellantis ( STLA ) halted work on its Jeep Compass sport utility vehicle model and activities at its assembly plant in Ontario, Canada as the company evaluates its product strategy in North America, news outlets reported Thursday, citing a statement from a company spokesperson. Citing a June 2024 company fact sheet, Reuters said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved